Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1401775Generated: October 31, 2026

4,4-Dimethyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydronaphthalen-1(2H)-one → 7-{2-[4-(2-hydroxyethylamino)piperidin-1-yl]thiazol-4-yl}-4,4-dimethyl-3,4-dihydro-2H-naphthalen-1-one

https://huagongshe.com/reaction/1401775

Reaction equation

Participants

RoleNameHCIDCharge
Reactant4,4-Dimethyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydronaphthalen-1(2H)-oneHCID 67323273—
Reactant2-(1-(4-Bromothiazol-2-yl)piperidin-4-ylamino)ethanolHCID 67323340—
Product7-{2-[4-(2-hydroxyethylamino)piperidin-1-yl]thiazol-4-yl}-4,4-dimethyl-3,4-dihydro-2H-naphthalen-1-oneHCID 67376919—

Reaction Steps

The preparation is carried out as already described above starting from 100 mg (0.27 mmol) of 2-[1-(4-bromothiazol-2-yl)piperidin-4-ylamino]ethanol (preparation already described above) and 88 mg (0.29 mmol) of 4,4-dimethyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-naphthalen-1-one. The product was purified by means of flash chromatography on silica gel.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08907098B2
Source datasetuspto-grants-2014_12
ORD IDord-22ed3085e3eb4814aa37e581afddd375
Source noteuspto-grants-2014_12